Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Dec;40(Suppl 2):123-127.
doi: 10.1007/s40273-022-01226-7. Epub 2022 Dec 12.

EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions

Affiliations
Editorial

EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions

Nancy Devlin et al. Pharmacoeconomics. 2022 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors are either members of the EuroQol Group or are directly employed by the EuroQol Research Foundation.

Figures

Fig. 1
Fig. 1
EQ-5D-Y-3L questionnaire: descriptive system. © EuroQol Research Foundation. Source: EQ-5D-Y User Guide

References

    1. Lamb A, Murray A, Lovett R. The challenges of measuring and valuing quality of life in preschool children: a retrospective review of NICE appraisals. Children. 2021;8(9):765. doi: 10.3390/children8090765. - DOI - PMC - PubMed
    1. Herdman M, Cole A, Hoyle CK, Coles V, Carroll S, Devlin N. Sources and characteristics of utility weights for economic evaluation of pediatric vaccines: a systematic review. Value Health. 2016;19:255–266. doi: 10.1016/j.jval.2015.11.003. - DOI - PubMed
    1. Kromm SK, Bethell J, Kraglund F, Edwards S, Laporte A, Coyte PC, Ungar WJ. Characteristics and quality of pediatric cost-utility analyses. Qual Life Res. 2012;21:1315–1325. doi: 10.1007/s11136-011-0049-7. - DOI - PubMed
    1. Bailey C, Dalziel K, Cronin P, et al. How are child-specific utility instruments used in decision making in Australia? A review of pharmaceutical benefits advisory committee public summary documents. Pharmacoeconomics. 2022;2022(40):157–182. doi: 10.1007/s40273-021-01107-5. - DOI - PMC - PubMed
    1. Ravens-Sieberer U, Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, Egmar AC, Gusi N, Herdman M, Jelsma J, Kind P, Olivares PR, Scalone L, Greiner W. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study. Qual Life Res. 2010;19(6):887–897. doi: 10.1007/s11136-010-9649-x. - DOI - PMC - PubMed

Publication types

LinkOut - more resources